메뉴 건너뛰기




Volumn 22, Issue 6 B, 2002, Pages 3621-3627

A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil

Author keywords

Chemotherapy; Cisplatin; Esophageal cancer; Infusional 5 FU; Methotrexate

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

EID: 0036875569     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (43)
  • 1
    • 0028025122 scopus 로고
    • Surgery for cancer of the esophagus
    • Roth JA and Putnam JB Jr: Surgery for cancer of the esophagus. Semin Oncol 21: 453-461, 1994.
    • (1994) Semin Oncol , vol.21 , pp. 453-461
    • Roth, J.A.1    Putnam J.B., Jr.2
  • 2
    • 0003323901 scopus 로고    scopus 로고
    • Cancer of the esophagus
    • (DeVita VT, Jr, Hellman S and Rosenberg SA, eds). Philadelphia, Lippincott Williams & Wilkins
    • th ed. (DeVita VT, Jr, Hellman S and Rosenberg SA, eds). Philadelphia, Lippincott Williams & Wilkins, 2001, pp 1051-91.
    • (2001) th Ed. , pp. 1051-1091
    • Schrump, D.S.1    Altorki, N.K.2    Forastiere, A.A.3    Minsky, B.D.4
  • 7
    • 0035863382 scopus 로고    scopus 로고
    • Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma
    • Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A and Strawderman M: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305-313, 2001.
    • (2001) J Clin Oncol , vol.19 , pp. 305-313
    • Urba, S.G.1    Orringer, M.B.2    Turrisi, A.3    Iannettoni, M.4    Forastiere, A.5    Strawderman, M.6
  • 8
    • 0000797109 scopus 로고    scopus 로고
    • Preliminary results of Intergroup INT 0123 randomized trial of combined modality therapy (CMT) for esophageal cancer: Standard vs. high dose radiation therapy
    • Abstr 927
    • Minsky BD, Berkey B, Kelsen DK, Ginsberg R, Pisansky T, Martenson J, Komaki R, Okawara G and Rosenberg S: Preliminary results of Intergroup INT 0123 randomized trial of combined modality therapy (CMT) for esophageal cancer: standard vs. high dose radiation therapy. Proc Am Soc Clin Oncol 19: Abstr 927, 2000.
    • (2000) Proc Am Soc Clin Oncol , vol.19
    • Minsky, B.D.1    Berkey, B.2    Kelsen, D.K.3    Ginsberg, R.4    Pisansky, T.5    Martenson, J.6    Komaki, R.7    Okawara, G.8    Rosenberg, S.9
  • 9
    • 0032703713 scopus 로고    scopus 로고
    • Chemotherapy in esophageal cancer
    • Enzinger PC, Ilson DH and Kelson DP: Chemotherapy in esophageal cancer. Semin Oncol 26(5, Suppl 15): 12-20, 1999.
    • (1999) Semin Oncol , vol.26 , Issue.5 SUPPL. 15 , pp. 12-20
    • Enzinger, P.C.1    Ilson, D.H.2    Kelson, D.P.3
  • 10
    • 0030791024 scopus 로고    scopus 로고
    • Chemotherapy in esophageal cancer: A review
    • Kok TC: Chemotherapy in esophageal cancer: a review. Cancer Treat Rev 23: 65-85, 1997.
    • (1997) Cancer Treat Rev , vol.23 , pp. 65-85
    • Kok, T.C.1
  • 11
    • 0032948716 scopus 로고    scopus 로고
    • The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen
    • Lokich JJ, Anderson N, Bern M, Coco F and Dow E: The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen. Cancer 85: 499-503, 1999.
    • (1999) Cancer , vol.85 , pp. 499-503
    • Lokich, J.J.1    Anderson, N.2    Bern, M.3    Coco, F.4    Dow, E.5
  • 13
    • 0031802997 scopus 로고    scopus 로고
    • Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - A very effective regimen with good patients' compliance for advanced gastric cancer
    • Cheng AL, Yeh KH, Lin JT, Hsu C and Liu MY: Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL) - a very effective regimen with good patients' compliance for advanced gastric cancer. Anticancer Res 18: 1267-1272, 1998.
    • (1998) Anticancer Res , vol.18 , pp. 1267-1272
    • Cheng, A.L.1    Yeh, K.H.2    Lin, J.T.3    Hsu, C.4    Liu, M.Y.5
  • 14
    • 0031438467 scopus 로고    scopus 로고
    • A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
    • Yeh KH, Cheng AL, Lin MT, Hong RL, Hsu CH, Lin JF, Chang KJ, Lee PH and Chen YC: A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers. Anticancer Res 17: 3867-3871, 1997.
    • (1997) Anticancer Res , vol.17 , pp. 3867-3871
    • Yeh, K.H.1    Cheng, A.L.2    Lin, M.T.3    Hong, R.L.4    Hsu, C.H.5    Lin, J.F.6    Chang, K.J.7    Lee, P.H.8    Chen, Y.C.9
  • 15
    • 0030964196 scopus 로고    scopus 로고
    • Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition
    • Hsu CH, Yeh KH, Chen LT, Liu JM, Jan CM, Lin JT, Chen YC and Cheng AL: Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition. Oncology 54: 275-280, 1997.
    • (1997) Oncology , vol.54 , pp. 275-280
    • Hsu, C.H.1    Yeh, K.H.2    Chen, L.T.3    Liu, J.M.4    Jan, C.M.5    Lin, J.T.6    Chen, Y.C.7    Cheng, A.L.8
  • 16
    • 0028866828 scopus 로고
    • Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma
    • Chi KH, Chan WK, Shu CH, Law CK, Chen SY, Yen SH and Chen KY: Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma. Cancer 76: 2186-2192, 1995.
    • (1995) Cancer , vol.76 , pp. 2186-2192
    • Chi, K.H.1    Chan, W.K.2    Shu, C.H.3    Law, C.K.4    Chen, S.Y.5    Yen, S.H.6    Chen, K.Y.7
  • 18
    • 0012824959 scopus 로고
    • Unusual neurotoxicity during 24-hour infusion of high-dose 5-fluorouracil and folinic acid in malnourished hypotriglyceridemic cancer patients
    • Abstract
    • Yeh KH, Cheng AL, Chen YC, Lin MT, Hong RL and Hsieh CY: Unusual neurotoxicity during 24-hour infusion of high-dose 5-fluorouracil and folinic acid in malnourished hypotriglyceridemic cancer patients. Proc Am Soc Clin Oncol 14: 167 (Abstract), 1995.
    • (1995) Proc Am Soc Clin Oncol , vol.14 , pp. 167
    • Yeh, K.H.1    Cheng, A.L.2    Chen, Y.C.3    Lin, M.T.4    Hong, R.L.5    Hsieh, C.Y.6
  • 19
    • 0031025605 scopus 로고    scopus 로고
    • High-dose 5-fluorouracil infusional therapy is associated with hyperammonemia, lactic acidosis, and encephalopathy
    • Yeh KH and Cheng AL: High-dose 5-fluorouracil infusional therapy is associated with hyperammonemia, lactic acidosis, and encephalopathy. Br J Cancer 75: 464-465, 1997.
    • (1997) Br J Cancer , vol.75 , pp. 464-465
    • Yeh, K.H.1    Cheng, A.L.2
  • 20
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 22
    • 15144352322 scopus 로고    scopus 로고
    • 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial
    • The French Associations for Surgical Research
    • Levard H, Pouliquen X, Hay JM, Fingerhut A, Langlois-Zantain O, Huguier M, Lozach P and Testart J: 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research. Eur J Surg 164: 849-857, 1998.
    • (1998) Eur J Surg , vol.164 , pp. 849-857
    • Levard, H.1    Pouliquen, X.2    Hay, J.M.3    Fingerhut, A.4    Langlois-Zantain, O.5    Huguier, M.6    Lozach, P.7    Testart, J.8
  • 23
    • 0027980010 scopus 로고
    • Preclinical and clinical aspects of biomodulation of 5-fluorouracil
    • Sotos GA, Grogan L and Allegra CJ: Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer Treat Rev 20: 11-49, 1994.
    • (1994) Cancer Treat Rev , vol.20 , pp. 11-49
    • Sotos, G.A.1    Grogan, L.2    Allegra, C.J.3
  • 24
    • 0002548405 scopus 로고    scopus 로고
    • 5-Fluoropyrimidines
    • (Chabner BA and Longo DL,eds). Philadelphia, Lippincott-Raven Publishers
    • Grem JL: 5-Fluoropyrimidines. In: Cancer Chemotherapy and Biotherapy, 2nd ed. (Chabner BA and Longo DL,eds). Philadelphia, Lippincott-Raven Publishers. 1996, pp 149-211.
    • (1996) Cancer Chemotherapy and Biotherapy, 2nd Ed. , pp. 149-211
    • Grem, J.L.1
  • 27
    • 0026721532 scopus 로고
    • Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
    • Advanced Colorectal Cancer Meta-analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10: 876-903, 1992
    • (1992) J Clin Oncol , vol.10 , pp. 876-903
  • 30
    • 0024414365 scopus 로고
    • Superiority of sequential methotrexate, fluorouracil and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: A randomized trial
    • The Nodic Gastrointestinal Tumor Adjuvant Therapy Group: Superiority of sequential methotrexate, fluorouracil and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial. J Clin Oncol 7: 1437-1446, 1989.
    • (1989) J Clin Oncol , vol.7 , pp. 1437-1446
  • 32
    • 0000368215 scopus 로고    scopus 로고
    • Antifolates
    • (Chabner BA and Longo DL,eds). Philadelphia, Lippincott-Raven Publishers
    • Chu E and Allegra CJ: Antifolates. In: Cancer Chemotherapy and Biotherapy, 2nd ed. (Chabner BA and Longo DL,eds). Philadelphia, Lippincott-Raven Publishers. 1996, pp 109-148.
    • (1996) Cancer Chemotherapy and Biotherapy, 2nd Ed. , pp. 109-148
    • Chu, E.1    Allegra, C.J.2
  • 33
    • 0026489375 scopus 로고
    • Inhibition by 5-fluorouracil of cisdiamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line
    • Esaki T, Nakano S, Tatsumoto T, Kuroki-Migita M, Mitsugi K, Nakamura M and Niho Y: Inhibition by 5-fluorouracil of cisdiamminedichloroplatinum(II)-induced DNA interstrand cross-link removal in a HST-1 human squamous carcinoma cell line. Cancer Res 52: 6501-6506, 1992.
    • (1992) Cancer Res , vol.52 , pp. 6501-6506
    • Esaki, T.1    Nakano, S.2    Tatsumoto, T.3    Kuroki-Migita, M.4    Mitsugi, K.5    Nakamura, M.6    Niho, Y.7
  • 34
    • 0026518341 scopus 로고
    • In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line
    • Kuroki M, Nakano S, Mitsugi K, Ichinose I, Anzai K, Nakamura M, Nagafuchis and Niho Y: In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line. Cancer Chemother Pharmacol 29: 273-276, 1992.
    • (1992) Cancer Chemother Pharmacol , vol.29 , pp. 273-276
    • Kuroki, M.1    Nakano, S.2    Mitsugi, K.3    Ichinose, I.4    Anzai, K.5    Nakamura, M.6    Nagafuchis7    Niho, Y.8
  • 35
    • 0024328984 scopus 로고
    • Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer
    • Vokes EE, Moran WJ, Mick R, Weichselbaum RR and Panje WR: Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer. J Clin Oncol 7: 838-845, 1989.
    • (1989) J Clin Oncol , vol.7 , pp. 838-845
    • Vokes, E.E.1    Moran, W.J.2    Mick, R.3    Weichselbaum, R.R.4    Panje, W.R.5
  • 36
    • 0026675626 scopus 로고
    • Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer
    • Lynch TJ, Clark JR, Kalish LA, Fallon BG, Elias AD, Skarin A and Frei E 3rd: Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer. Cancer 70: 1880-1885, 1992.
    • (1992) Cancer , vol.70 , pp. 1880-1885
    • Lynch, T.J.1    Clark, J.R.2    Kalish, L.A.3    Fallon, B.G.4    Elias, A.D.5    Skarin, A.6    Frei E. III7
  • 38
    • 0034442011 scopus 로고    scopus 로고
    • Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: A phase II study of the Italian Oncology Group for Clinical Research (GOIRC)
    • Di Costanzo F, Canaletti R, Sdrobolini A, Olmeo N, Luppi G, Pucci F, Cavicchi F, Gasperoni S, Rodino C, Zironi S, Angiona S and Contu A: Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC). Am J Clin Oncol 23: 314-318, 2000.
    • (2000) Am J Clin Oncol , vol.23 , pp. 314-318
    • Di Costanzo, F.1    Canaletti, R.2    Sdrobolini, A.3    Olmeo, N.4    Luppi, G.5    Pucci, F.6    Cavicchi, F.7    Gasperoni, S.8    Rodino, C.9    Zironi, S.10    Angiona, S.11    Contu, A.12
  • 39
    • 0033214636 scopus 로고    scopus 로고
    • A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma
    • Oh WK, Manola J, Richie JP, Loughlin KR and Kantoff PW: A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma. Cancer 86: 1329-1334, 1999.
    • (1999) Cancer , vol.86 , pp. 1329-1334
    • Oh, W.K.1    Manola, J.2    Richie, J.P.3    Loughlin, K.R.4    Kantoff, P.W.5
  • 40
    • 0033558006 scopus 로고    scopus 로고
    • A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck
    • Caponigro F, Comella P, Marcolin P, Russo Spena F, Biglietto M, Carteni G, De Lucia L, Avallone A, Gravina A and Comella G: A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck. Cancer 85: 952-959, 1999.
    • (1999) Cancer , vol.85 , pp. 952-959
    • Caponigro, F.1    Comella, P.2    Marcolin, P.3    Russo Spena, F.4    Biglietto, M.5    Carteni, G.6    De Lucia, L.7    Avallone, A.8    Gravina, A.9    Comella, G.10
  • 41
    • 0028292179 scopus 로고
    • Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus
    • Ajani JA, Ilson DH, Daugherty K, Pazdur R, Lynch PM and Kelsen DP: Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86: 1086-1091, 1994.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 1086-1091
    • Ajani, J.A.1    Ilson, D.H.2    Daugherty, K.3    Pazdur, R.4    Lynch, P.M.5    Kelsen, D.P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.